語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Tumor immunosurveillance by natural ...
~
Venook, Rayna Takaki.
FindBook
Google Book
Amazon
博客來
Tumor immunosurveillance by natural killer cells.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Tumor immunosurveillance by natural killer cells./
作者:
Venook, Rayna Takaki.
面頁冊數:
82 p.
附註:
Source: Dissertation Abstracts International, Volume: 67-08, Section: B, page: 4242.
Contained By:
Dissertation Abstracts International67-08B.
標題:
Biology, Microbiology. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3229275
ISBN:
9780542828973
Tumor immunosurveillance by natural killer cells.
Venook, Rayna Takaki.
Tumor immunosurveillance by natural killer cells.
- 82 p.
Source: Dissertation Abstracts International, Volume: 67-08, Section: B, page: 4242.
Thesis (Ph.D.)--University of California, San Francisco, 2006.
Natural killer cells are an integral component of the innate immune response that can quickly detect and eliminate infected or transformed cells without requiring prior sensitization. It has been demonstrated that NK cells play an important role in tumor immunosurveillance; however, the mechanisms regulating NK cell anti-tumor activity are still not well defined. The work presented in this thesis examines the effects of E1A-mediated transformation, interleukin-2I (IL-21) treatment, and DAP 12-mediated signaling on NK cell-mediated tumor rejection.
ISBN: 9780542828973Subjects--Topical Terms:
1017734
Biology, Microbiology.
Tumor immunosurveillance by natural killer cells.
LDR
:03177nmm 2200313 4500
001
1831058
005
20070507072922.5
008
130610s2006 eng d
020
$a
9780542828973
035
$a
(UnM)AAI3229275
035
$a
AAI3229275
040
$a
UnM
$c
UnM
100
1
$a
Venook, Rayna Takaki.
$3
1919870
245
1 0
$a
Tumor immunosurveillance by natural killer cells.
300
$a
82 p.
500
$a
Source: Dissertation Abstracts International, Volume: 67-08, Section: B, page: 4242.
500
$a
Adviser: Lewis Lanier.
502
$a
Thesis (Ph.D.)--University of California, San Francisco, 2006.
520
$a
Natural killer cells are an integral component of the innate immune response that can quickly detect and eliminate infected or transformed cells without requiring prior sensitization. It has been demonstrated that NK cells play an important role in tumor immunosurveillance; however, the mechanisms regulating NK cell anti-tumor activity are still not well defined. The work presented in this thesis examines the effects of E1A-mediated transformation, interleukin-2I (IL-21) treatment, and DAP 12-mediated signaling on NK cell-mediated tumor rejection.
520
$a
The ability of human adenovirus serotype 5 E1A, a viral oncoprotein, to sensitize tumor cells to NK cell-mediated lysis has been well demonstrated; however, the mechanisms regulating this sensitivity were previously unknown. We demonstrated that transformation of select tumor cells by E1A up-regulated NKG2D ligand expression on the tumor cells and, thereby, sensitized the tumor cells to NKG2D-dependent NK cell-mediated cytolytic activity. This E1A-induced sensitivity to NKG2D-dependent NK cell cytolytic activity enhanced tumor rejection, and mice injected with E1A-transformed tumor cells remained tumor free at significantly higher tumor cells doses compared to mice that were injected with parental cells not expressing E1A.
520
$a
Next, we demonstrated that NK cell-mediated tumor rejection is enhanced by IL-21 treatment. Mice treated with IL-21 rejected select tumor cells more efficiently, and they remained tumor-free longer than untreated control mice. Additionally, we demonstrated that the IL-21-enhanced tumor rejection by NK cells was mediated by the NKG2D pathway and did not require the presence of an adaptive immune system. Finally, we demonstrated that DAP12 is an adapter protein with dual functionality that can activate and inhibit NK cell effector functions. We observed that DAP12-deficient NK cells exhibit hyper-responsive cytolytic activity and cytokine production. Furthermore, in vivo, the absence of DAP12 enhanced NK cell-mediated tumor rejection; and DAP12-deficient mice rejected tumor cells more efficiently than wild-type mice. These findings were consistent with our previous observations demonstrating that the absence of DAP12 enhances myeloid effector functions.
590
$a
School code: 0034.
650
4
$a
Biology, Microbiology.
$3
1017734
650
4
$a
Health Sciences, Immunology.
$3
1017716
650
4
$a
Health Sciences, Oncology.
$3
1018566
690
$a
0410
690
$a
0982
690
$a
0992
710
2 0
$a
University of California, San Francisco.
$3
1025118
773
0
$t
Dissertation Abstracts International
$g
67-08B.
790
1 0
$a
Lanier, Lewis,
$e
advisor
790
$a
0034
791
$a
Ph.D.
792
$a
2006
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3229275
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9221921
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入